Researchers identify biomarker that could predict disease severity in glaucoma patients
Can't see this email? View it online
   
  May 28, 2017  
  Glaucoma  
  The latest glaucoma news from News Medical  
 Researchers identify biomarker that could predict disease severity in glaucoma patientsResearchers identify biomarker that could predict disease severity in glaucoma patients
 
Glaucoma, a leading cause of blindness worldwide, most often is diagnosed during a routine eye exam. Over time, elevated pressure inside the eye damages the optic nerve, leading to vision loss. Unfortunately, there's no way to accurately predict which patients might lose vision most rapidly.
 
 
 Powerful pain medicine may help reduce vision damage of glaucomaPowerful pain medicine may help reduce vision damage of glaucoma
 
The tip of our optic nerve is typically the first place injured by glaucoma. Now researchers want to know if the powerful pain medicine (+)-pentazocine can help avoid the damage.
 
   UAB professor receives $1.5 million grant to explore links between circadian fluctuations and glaucomaUAB professor receives $1.5 million grant to explore links between circadian fluctuations and glaucoma
 
Brian Samuels, M.D., Ph.D., assistant professor in the University of Alabama at Birmingham Department of Ophthalmology, has received a five-year, $1.5 million grant from the National Eye Institute to explore the links between circadian fluctuations and glaucoma. This is Samuels' first R01 grant.
 
   Newly-developed smart contact lens sensor may help diagnose diabetes and glaucomaNewly-developed smart contact lens sensor may help diagnose diabetes and glaucoma
 
A recent study, affiliated with UNIST has proposed the possibility of in situ human health monitoring simply by wearing a contact lens with built-in wireless smart sensors.
 
   Scientists show ability to grow specific neurons for treatment of optic neurodegenerative diseasesScientists show ability to grow specific neurons for treatment of optic neurodegenerative diseases
 
Scientists have demonstrated the capacity to grow specialized neurons that relay visual data to the brain, creating a source of cells for future treatments of glaucoma and other optic neurodegenerative diseases.
 
 Research reveals 9.8 million Brits risk losing their sight after shunning eye tests
 
Research reveals 9.8 million Brits risk losing their sight after shunning eye testsThe Vision of Britain report, commissioned by Optegra Eye Health Care, shows an alarming percentage of Britain’s eye problems are left too late to treat, leaving 9.8 million of us living in fear of losing our sight.
 
 
 ARVO 2017 to showcase latest advances in treatments for eye disease and blindness
 
ARVO 2017 to showcase latest advances in treatments for eye disease and blindnessThe Annual Meeting of the Association for Research in Vision and Ophthalmology is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries.
 
 
 Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant
 
Study: Systemic therapy preserves vision of uveitis patients better than intraocular implantSystemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better - and had fewer adverse outcomes - than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute.
 
 
 Electrical stimulation of the brain may help preserve visual neurons from cell death after injury
 
Electrical stimulation of the brain may help preserve visual neurons from cell death after injuryElectrical stimulation of the brain by applying current to the eye may help retinal nerve cells to survive injury. While these neurons may not be restored to full function, they are prevented from dying. But to achieve survival, their interconnections, the dendritic tree, needs to disconnect rapidly for the protective action to unfold.